Sentences with phrase «clinical research studies across»

Not exact matches

Despite finding that underreporting continues to be what she wrote in two 2013 studies to be an «alarming» [17] and «overwhelming» problem, [16] Johna Register - Mihalik, Ph.D, LAT, ATC, Senior Research Associate at WakeMed and Adjunct Assistant Professor at UNC - Chapel Hill, told MomsTEAM that the the reason the use of impact sensors was not among the recommendations she and her co-authors in those studies made to address the problem of chronic underreporting was that she viewed «the use of impact sensors in concussion detection, as the science, although a growing field of information, is just not quite there in how these may best be used from a clinical standpoint and across all sport settings.»

Despite finding that underreporting continues to be what she wrote in two 2013 studies to be an «alarming» and «overwhelming» problem, Dr. Johna Register - Mihalik, a research scientist and member of the faculty at the Matthew Gfeller Sport - Related TBI Research Center at the University of North Carolina at Chapel Hill, recently told MomsTEAM that the reason she and her colleagues did not recommend the use of impact sensors in addressing the problem was that she viewed «the use of impact sensors in concussion detection, as the science, although a growing field of information, [as] just not quite there in [terms of] how the [y] may best be used from a clinical standpoint and across all sport settingsresearch scientist and member of the faculty at the Matthew Gfeller Sport - Related TBI Research Center at the University of North Carolina at Chapel Hill, recently told MomsTEAM that the reason she and her colleagues did not recommend the use of impact sensors in addressing the problem was that she viewed «the use of impact sensors in concussion detection, as the science, although a growing field of information, [as] just not quite there in [terms of] how the [y] may best be used from a clinical standpoint and across all sport settingsResearch Center at the University of North Carolina at Chapel Hill, recently told MomsTEAM that the reason she and her colleagues did not recommend the use of impact sensors in addressing the problem was that she viewed «the use of impact sensors in concussion detection, as the science, although a growing field of information, [as] just not quite there in [terms of] how the [y] may best be used from a clinical standpoint and across all sport settings.»

A damning report on how the University of Minnesota (UM) protects volunteers in its clinical trials concludes that researchers inadequately reviewed research studies across the university and need more training to better protect the most vulnerable subjects.

As part of a clinical study, a nasopharyngeal swab is sent across town to the Naval Health Research Center (NHRC).

► «A damning report on how the University of Minnesota (UM) protects volunteers in its clinical trials concludes that researchers inadequately reviewed research studies across the university and need more training to better protect the most vulnerable subjects,» Jennifer Couzin - Frankel wrote Monday at ScienceInsider.

That guidance had a chilling effect across all stages of clinical research, notes a 2012 report from the Institute of Medicine: Biomedical researchers were afraid to include women in their studies.

Professor Cyrus Cooper, Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit, University of Southampton, added: «This study forms part of a larger programme of work addressing risk factors for fracture across the lifecourse, and demonstrates the importance of the University of Southampton and MRC Lifecourse Epidemiology Unit in leading large, UK wide analyses on the internationally leading UK Clinical Practice Research Datalink dataset.

NEW YORK and SAN FRANCISCO, March 28, 2017 — The Parker Institute for Cancer Immunotherapy, Bristol - Myers Squibb Company (NYSE: BMY) and the Cancer Research Institute (CRI) today announced a multi-year clinical research collaboration to coordinate and rapidly initiate clinical Immuno - Oncology (I - O) studies across the Parker Institute and CRI nResearch Institute (CRI) today announced a multi-year clinical research collaboration to coordinate and rapidly initiate clinical Immuno - Oncology (I - O) studies across the Parker Institute and CRI nresearch collaboration to coordinate and rapidly initiate clinical Immuno - Oncology (I - O) studies across the Parker Institute and CRI networks.

While there is still no universal agreement on a precise clinical presentation encompassing CFS illness, defining patient characteristics in studies of CFS etiology or pathogenesis remains crucial for making comparisons across various research conclusions.

In a substudy, review outcomes were also compared across different types of clinical research, based in large part on the designations and definitions derived from a number of sources, including a report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanclinical research, based in large part on the designations and definitions derived from a number of sources, including a report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanresearch, based in large part on the designations and definitions derived from a number of sources, including a report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanClinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanResearch, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanResearch and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanclinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanclinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanresearch focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanresearch; and (7) use of deidentified human tissue.

5/21/2007 Nationwide Study Compares Surgeries to Treat Urinary Incontinence in Women The University of California, San Diego Medical Center along with nine other clinical research institutions across the United States has completed the largest randomized clinical trial to date comparing two commonly performed surgical procedures to t...

Biomedical research, including genomic and epidemiologic studies, are now impacting clinical practice, and precise, consistent phenotypes are essential for investigators and clinicians to effectively communicate across all stages of the «bench to bedside» continuum.

The ECOG - ACRIN Cancer Research Group contains an Imaging Core Laboratory to support a wide range of clinical trials associated with imaging that are developed across the Group's three scientific programs: Cancer Control and Outcomes, Therapeutic Studies, and Biomarker Sciences.

«His meta - analysis of the cutting - edge research on large - cohort studies of what sugar does to populations across the world, alongside his own clinical observations, has him credited with starting the war on sugar,» writes Zoe William in The Guardian.

Group Pension and Administrators (Richardson, TX) 2007 — 2010 Medical Data / Reporting Analyst • Implemented tactics to decreased time for generating specialized reports by 50 % on clinical financial research • Researched case studies needing Benefit Modelers and benchmark resulting in efficient aid in negotiations and cost analysis • Analyzed / interpreted data, problem solved, and communicated solutions for a variety of issues across multiple departments • Provided multiple solutions for cost drivers using medical related software showing cause and effect relationships

Many of the scales demonstrated weak psychometrics in at least one of the following ways: (a) lack of psychometric data [i.e., reliability and / or validity; e.g., HFQ, MASC, PBS, Social Adjustment Scale - Self - Report (SAS - SR) and all perceived self - esteem and self - concept scales], (b) items that fall on more than one subscale (e.g., CBCL - 1991 version), (c) low alpha coefficients (e.g., below.60) for some subscales, which calls into question the utility of using these subscales in research and clinical work (e.g., HFQ, MMPI - A, CBCL - 1991 version, BASC, PSPCSAYC), (d) high correlations between subscales (e.g., PANAS - C), (e) lack of clarity regarding clinically - relevant cut - off scores, yielding high false positive and false negative rates (e.g., CES - D, CDI) and an inability to distinguish between minor (i.e., subclinical) and major (i.e., clinical) «cases» of a disorder (e.g., depression; CDI, BDI), (f) lack of correspondence between items and DSM criteria (e.g., CBCL - 1991 version, CDI, BDI, CES - D, (g) a factor structure that lacks clarity across studies (e.g., PSPCSAYC, CASI; although the factor structure is often difficult to assess in studies of pediatric populations, given the small sample sizes), (h) low inter-rater reliability for interview and observational methods (e.g., CGAS), (i) low correlations between respondents such as child, parent, teacher [e.g., BASC, PSPCSAYC, CSI, FSSC - R, SCARED, Connors Ratings Scales - Revised (CRS - R)-RSB-, (j) the inclusion of somatic or physical symptom items on mental health subscales (e.g., CBCL), which is a problem when conducting studies of children with pediatric physical conditions because physical symptoms may be a feature of the condition rather than an indicator of a mental health problem, (k) high correlations with measures of social desirability, which is particularly problematic for the self - related rating scales and for child - report scales more generally, and (l) content validity problems (e.g., the RCMAS is a measure of anxiety, but contains items that tap mood, attention, peer interactions, and impulsivity).